Loading organizations...
Loading organizations...
D2C Skincare for Eczema
Key people at SOTERI SKIN.
SOTERI SKIN was founded in 2021 by Rafal Pielak (Founder).
Soteri Skin is D2C skincare for chronic skin conditions like eczema. We’re the only non-prescription product proven to provide long-lasting relief for the 30 million Americans who suffer from eczema.
How it works:
Skin surface pH is constantly in flux, and many of your daily activities can throw it out of balance. People with chronic skin conditions such as eczema have a harder time regulating their skin's pH.
Soteri's patented pH/LOCK™ locks skin in at a therapeutic pH for 12+ hours, which is shown to help break the cycle of skin sensitivity, whether you have eczema, psoriasis, or just a bad sunburn.
Our formulations are aesthetically elegant (non-sticky, sit well under makeup, etc), safe for anyone to use, and don't require a prescription. Most people see skin health improvements within the first few weeks of application, even for tricky, chronic skin conditions like eczema and psoriasis.
With Soteri Skin, anyone can enjoy healthy, glowing, pH-enomenal skin!
SOTERI SKIN was founded in 2021 by Rafal Pielak (Founder).
Key people at SOTERI SKIN.
Soteri Skin is a direct-to-consumer (D2C) medical skincare startup specializing in non-steroidal treatments for eczema (atopic dermatitis). It offers a patented pH/LOCK™ complex technology that corrects and stabilizes skin pH to restore the skin barrier, reduce inflammation, and provide long-lasting relief from eczema flare-ups. The product is uniquely formulated for delicate skin, including babies, and is clean, vegan, fragrance-free, and free of preservatives that can irritate sensitive skin[1][2][3][4].
The company serves individuals suffering from chronic eczema, particularly those seeking effective, non-steroidal topical treatments that address the root cause rather than just symptoms. Soteri Skin has demonstrated growth momentum by leveraging its patented technology and Harvard-backed scientific credibility to differentiate itself in a crowded market of eczema creams that often fail to provide lasting relief[2][3].
Soteri Skin was founded by Dr. Rafal Pielak, a Harvard Biomedical Sciences PhD and postdoctoral fellow at UC Berkeley, who was inspired by his wife’s struggle with eczema during pregnancy. Frustrated by the lack of effective treatments, he researched the connection between skin pH imbalance and eczema symptoms, leading to the development of the patented pH/LOCK™ complex. The startup was incubated at Harvard Innovation Labs and has since evolved into a company focused on delivering a scientifically validated, non-steroidal eczema treatment[2][3].
Dr. Pielak’s background includes leadership roles in biotech product innovation and experience with major skincare brands through the L’Oréal Tech Incubator, which helped shape Soteri Skin’s approach to product development and market entry[2].
Soteri Skin rides the growing trend of personalized, science-driven skincare solutions that move beyond symptom management to address underlying causes. The timing is favorable due to increasing consumer demand for clean, non-steroidal, and effective dermatological products, especially for chronic conditions like eczema that affect millions globally. Advances in biomedical research and the rise of D2C brands empower startups like Soteri Skin to disrupt traditional pharmaceutical and skincare markets by offering innovative, accessible treatments.
By focusing on skin pH balance—a relatively underexplored mechanism in eczema treatment—Soteri Skin contributes to expanding the scientific understanding and therapeutic options in dermatology. Its success encourages further innovation in medical skincare and supports the broader ecosystem of biotech-driven consumer health startups[1][2][4].
Soteri Skin is well-positioned to expand its product line and market reach by leveraging its patented technology and strong scientific foundation. Future trends shaping its journey include increased consumer preference for non-steroidal, clean-label skincare, and growing awareness of skin microbiome and pH’s role in dermatological health. The company’s influence may evolve as it potentially partners with healthcare providers or integrates digital health tools to personalize eczema management further.
Continued innovation and clinical validation will be key to maintaining competitive advantage and scaling impact. Soteri Skin’s story—from a personal family challenge to a scientifically backed solution—resonates strongly with consumers seeking trustworthy, effective eczema care, anchoring its future growth and ecosystem influence[2][3].
